Nanoform Finland Oyj (NANOFH.HE)

EUR 1.29

(2.7%)

Total Liabilities Summary of Nanoform Finland Oyj

Nanoform Finland Oyj's latest annual total liabilities in 2023 was 11.18 Million EUR , down -16.69% from previous year.
Nanoform Finland Oyj's latest quarterly total liabilities in 2024 Q2 was 11.41 Million EUR , down -1.69% from previous quarter.
Nanoform Finland Oyj reported annual total liabilities of 13.42 Million EUR in 2022, down -9.63% from previous year.
Nanoform Finland Oyj reported annual total liabilities of 14.85 Million EUR in 2021, up 32.07% from previous year.
Nanoform Finland Oyj reported quarterly total liabilities of 11.6 Million EUR for 2024 Q1, up 3.76% from previous quarter.
Nanoform Finland Oyj reported quarterly total liabilities of 12.33 Million EUR for 2023 Q2, down -12.21% from previous quarter.

Annual Total Liabilities Chart of Nanoform Finland Oyj (2023 - 2016)

Historical Annual Total Liabilities of Nanoform Finland Oyj (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	11.18 Million EUR	-16.69%
2022	13.42 Million EUR	-9.63%
2021	14.85 Million EUR	32.07%
2020	11.25 Million EUR	126.01%
2019	4.97 Million EUR	56.78%
2018	3.17 Million EUR	205.34%
2017	1.03 Million EUR	82.31%
2016	570.41 Thousand EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	11.41 Million EUR	-1.69%
2024 Q1	11.6 Million EUR	3.76%
2023 Q2	12.33 Million EUR	-12.21%
2023 FY	11.18 Million EUR	-16.69%
2023 Q4	11.18 Million EUR	2.91%
2023 Q3	10.87 Million EUR	-11.87%
2023 Q1	14.05 Million EUR	4.64%
2022 Q1	13.76 Million EUR	-7.38%
2022 Q4	13.42 Million EUR	3.79%
2022 Q3	12.93 Million EUR	-4.3%
2022 Q2	13.52 Million EUR	-1.77%
2022 FY	13.42 Million EUR	-9.63%
2021 FY	14.85 Million EUR	32.07%
2021 Q4	14.85 Million EUR	17.58%
2021 Q3	12.63 Million EUR	26.81%
2021 Q2	9.96 Million EUR	-3.61%
2021 Q1	10.33 Million EUR	-8.11%
2020 FY	11.25 Million EUR	126.01%
2020 Q2	14.02 Million EUR	56.55%
2020 Q4	11.25 Million EUR	4.83%
2020 Q3	10.73 Million EUR	-23.46%
2020 Q1	8.95 Million EUR	79.91%
2019 Q4	4.97 Million EUR	0.0%
2019 Q1	- EUR	0.0%
2019 FY	4.97 Million EUR	56.78%
2018 FY	3.17 Million EUR	205.34%
2017 FY	1.03 Million EUR	82.31%
2016 FY	570.41 Thousand EUR	0.0%

Peer Total Liabilities Comparison of Nanoform Finland Oyj

Name	Total Liabilities	Total Liabilities Difference
Biohit Oyj	3.5 Million EUR	-219.66%
Herantis Pharma Oyj	2.01 Million EUR	-454.062%